Within the class S4 of hormone and metabolic modulators of the WADA Prohibited List, 39% of the adverse analytical findings (AAF) reported in 2020 resulted from SERMs (tamoxifen and clomiphene) and another 29% from AIs (letrozole, anastrozole, exemestane, and adrostatrienedione) (World Anti-Doping Agency, 2022)
Clinical data confirms low side effects with proper use
PRP treatment holds promise in promoting tissue healing and repair
Compared to many civilian insurance providers, TRICARE is often recognized for offering strong behavioral health coverage and access to trauma-informed care, especially for active-duty military families and veterans
In preclinical research dating back to the 1990s, BPC-157 has demonstrated remarkable effects across multiple body systems
NNMT is an enzyme that works in your cells to manage energy and metabolism